Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

Back

ESC Professional Premium Access

Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry

Session: Individual treatment strategies in atrial fibrillation

Topic: Diabetes and the Heart

Speaker: Professor G. Patti (Novara, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Giuseppe Patti

University of Eastern Piedmont, Novara (Italy)

4 presentations

0 follower

5 more presentations in this session

Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Speaker: Doctor H. Ahn (Seoul, KR)

Preterm birth, abnormal foetal growth and the risk of atrial fibrillation later in life: a cohort study in Denmark, Finland and Sweden

Speaker: Miss F. Yang (Stockholm, SE)

The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke

Speaker: Doctor S. Pallikadavath (Leicester, GB)

Heart failure and cardiovascular outcomes in european patients with atrial fibrillation

Speaker: Doctor N. Bonini (Modena, IT)

The comorbidity network in older adults with atrial fibrillation: a danish nationwide cohort study

Speaker: Doctor L. Dai (Stockholm, SE)

Access the full session

Individual treatment strategies in atrial fibrillation

Speakers: Professor G. Patti, Doctor H. Ahn, Miss F. Yang, Doctor S. Pallikadavath, Doctor N. Bonini...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources